Orlando Pharmacy Agrees To Pay Over $100,000 To Settle Controlled Substances Act Violations

Orlando, FL – United States Attorney Maria Chapa Lopez announces today that Florida Discount Drugs, Inc., which operates as Taylor’s Pharmacy, has agreed to pay the United States $107,500 to resolve allegations that it violated the Controlled Substances Act by improperly distributing schedule III and IV drugs, and committing multiple recordkeeping violations. The settlement relates to a Drug Enforcement Administration (DEA) investigation of Taylor’s Pharmacy. 

According to the settlement agreement, between February 15, 2012, and July 22, 2016, Taylor’s Pharmacy made 37 distributions of schedule III and schedule IV controlled substances, and an additional 31 distributions of controlled substances to two individuals not registered to receive those drugs. Then, on April 18, 2017, the DEA initiated an inspection of Taylor’s Pharmacy and determined that it had committed 18 recordkeeping violations of the Controlled Substances Act.

“Pharmacies have an obligation to ensure that controlled substances are properly tracked through the distribution chain,” said U.S. Attorney Maria Chapa Lopez. “This settlement highlights our commitment to enforcing the Controlled Substances Act and protecting our citizens.”

“The pharmaceutical industry has a vital role on the front lines of preventing drug misuse and abuse across America. This settlement demonstrates the important responsibilities all pharmacies have to prevent dangerous drugs from their intended misuse,” said Susan Langston, Diversion Program Manager, Miami Field Division. “This civil resolution reached today is just one example of DEA’s determination to combat the troubling prescription drug abuse problem in this country by pursuing pharmacies that fail to comply with the law. Our nation’s pharmacies must play a major role in the fight against pharmaceutical drug abuse, so that together we can protect public health and keep our communities safe.”

This settlement resulted from a coordinated effort by the Drug Enforcement Administration and the U.S. Attorney’s Office for the Middle District of Florida. It has handled by Assistant U.S. Attorney Jeremy R. Bloor.

The claims resolved by this settlement are allegations only. There has been no determination of liability.